Ginkgo Bioworks Holdings Inc (NYSE:DNA)
| 3.12 Delayed Data As of Oct 03 |  0.00 / 0.00%Today’s Change | 2.09 Today|||52-Week Range 15.86 | -62.45% Year-to-Date |
Latest DNA News | Press Releases
| Ginkgo Bioworks Holdings, Inc. (DNA) Gains But Lags Market: What You Should Know Oct 03 / Zacks.com - Paid Partner Content | Why Shares of Ginkgo Bioworks Bounded Higher This Week Sep 30 / MotleyFool.com - Paid Partner Content |
| Want to Invest Like Cathie Wood? Use These 3 Principles. Oct 02 / MotleyFool.com - Paid Partner Content | 3 Growth Stocks That Could Double Your Money, According to Wall Street Sep 29 / MotleyFool.com - Paid Partner Content |
| Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -0.32%: What You Should Know Sep 30 / Zacks.com - Paid Partner Content | Cathie Wood Goes Shopping for Biotech: 3 Stocks She Just Bought Sep 22 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.12 |
| Today’s open | 3.23 |
| Day’s range | 3.01 - 3.30 |
| Volume | 21,913,244 |
| Average volume (3 months) | 25,302,652 |
| Market cap | $5.0B |
Data as of 4:00pm ET, 10/03/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +25.36% |
| Earnings growth (next 5 years) | +36.23% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 42.67 |
| Price/Book | 3.35 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 14, 2022 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $313.8M |
| Annual profit (last year) | -$1.8B |
| Net profit margin | -583.12% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters --, -- |
Forecasts
